About 20 Mg Afatinib Tablets
Gilotrif 20 mg Afatinib Tablets are a top-notch, targeted therapy for EGFR-mutated Non-Small Cell Lung Cancer (NSCLC). Available in a scarce supply of premium 28-tablet blister packs, each tablet contains 20 mg Afatinib. These sublime, white to off-white film-coated tablets feature a top-drawer oral administration route-making them convenient for patients. Marked down as prescription only, with validated FDA and EMA approvals, Gilotrif is featured for its efficacy and sublime tolerability profile. Store below 30C. Use strictly under medical supervision. Not recommended during pregnancy or breastfeeding. Common side effects include diarrhea and skin reactions.
Key Advantages of 20 Mg Afatinib Tablets
The 20 mg Afatinib Tablets offer top-drawer targeted therapy, delivering sublime results in managing EGFR-mutated NSCLC. Featured with oral administration, the tablets ensure convenience and compliance for adult cancer patients. With a high-quality blister pack and a shelf life of up to 36 months, these tablets are suitable for patients requiring continuous, precise dosage regimens. Approved globally, they are made with premium excipients for optimal therapeutic impact and stability under recommended storage conditions.
Distribution & Export Markets for Afatinib Tablets
Primarily shipped and handed over across the Indian domestic market with robust supply ability, these 20 mg Afatinib Tablets are also supplied to regulated international markets. Goods are exported to regions like Southeast Asia, the Middle East, and Africa under controlled, compliant shipping standards. Charges are structured competitively to support distributors, exporters, suppliers, and traders across various markets. Prompt shipping timelines ensure swift delivery to meet urgent oncology treatment demands.
FAQ's of 20 Mg Afatinib Tablets:
Q: How should Gilotrif 20 mg Afatinib Tablets be administered?
A: Gilotrif 20 mg Afatinib Tablets are designed for oral administration and should be taken exactly as prescribed by a healthcare professional, typically once daily with water, without splitting or crushing the tablet.
Q: What is the primary benefit of using Afatinib Tablets in cancer therapy?
A: The tablets offer targeted therapy for EGFR-mutated Non-Small Cell Lung Cancer (NSCLC), aiming for maximum therapeutic impact while minimizing exposure to non-cancerous cells, leading to potentially better efficacy and tolerability.
Q: When are Afatinib Tablets contraindicated for use?
A: Afatinib Tablets are contraindicated in individuals with hypersensitivity to Afatinib or any of its excipients, and use is not recommended during pregnancy or breastfeeding due to potential risks.
Q: Where can these tablets be obtained?
A: 20 mg Afatinib Tablets can be sourced through prescription from authorized distributors, exporters, suppliers, or traders, particularly in India and internationally in markets where the product holds regulatory approval.
Q: What precautions should be followed during the usage of Gilotrif?
A: Patients must follow medical supervision strictly, monitor for common side effects such as diarrhea, skin rash, and stomatitis, and store the tablets in a cool, dry place below 30C. It is critical to adhere to the prescribed dosage and consultation schedules set by an oncologist.